Oliver Engert, Chief Administrative Officer of Enovis Corporation, purchased 7,598 shares of common stock in transactions on Sept. 2, 2026, and Sept. 3, 2026, according to a recent SEC Form 4 filing. The purchase was executed at a weighted average price of $19.74 per share, for a total transaction value of roughly $150,000, with the shares acquired in multiple transactions at price ranges of $19.33 to $19.75 and $20.145 to $20.50. The addition brings Engert's total direct holding to 61,238 shares, a stake of 0.11% in the $1.1 billion medical technology enterprise, worth about $1.19 million based on the Sept. 3, 2026 market close of $19.40. Enovis reported trailing twelve-month revenue of $2.3 billion and a net loss of $1.1 billion, while net debt stands at $1.36 billion. The stock closed at $18.56 on Sept. 4, 2026.
Enovis CorpChief Administrative Officer Oliver Engert bought 7,598 Enovis shares (~$150,000), an insider purchase signaling confidence.
